1-3 of 3
Qing Shi
Close
Sort by
Journal Articles

AML Immunotherapy Using a Novel Tcrm-Based Bispecific Antibody That Targets a Leader Sequence Peptide Derived from Cathepsin G

Chunhua Shi, Ze Tian, Jun Yan, Mao Zhang, Pariya Sukhumalchandra, Edward Chang, Guojun Yang, Junping You, Meng Cui, Qing Shi, Anne Philips, Na Qiao, Anna Sergeeva, Lisa St. John, Hong He, Dongxing Zha, Jeffrey J. Molldrem, Gheath Alatrash
Journal: Blood
Blood (2023) 142 (Supplement 1): 1415.
https://doi.org/10.1182/blood-2023-189514
Published: 2023
Journal Articles

The Role of Radiotherapy in Patients with Refractory Hodgkin Lymphoma after Brentuximab Vedotin and -/or Immune Checkpoint Inhibitors

Ting-Bo Liu, Xiaofan Li, Rui-Zhi Zhao, Han Shao, Gui-Qing Shi, Yan-Yan Qiu, Tian-Lan Tang, Yu-Ping Lin, Si-Lin Chen, Cheng Huang, Si-Qin Liao, Jin-Hua Chen, Hai-Ying Fu, Jian-Zhi Liu, Jian-Zhen Shen, Ben-Hua Xu, Yu-jing Zhang, Yong Yang
Journal: Blood
Blood (2023) 142 (Supplement 1): 6189.
https://doi.org/10.1182/blood-2023-184773
Published: 2023
Journal Articles

Targeting Myeloid Leukemia Using Novel TCR-like Chimeric Antigen Receptor-T Cells Against Cathepsin G

Jun Yan, Ze Tian, Chunhua Shi, Mao Zhang, Pariya Sukhumalchandra, Guojan Yang, Qing Edward Chang, Junping You, Meng Cui, Qing Shi, Anne Philip, Na Qiao, Anna Sergeeva, Lisa St John, Hong He, Dongxing Zha, Jeffrey J. Molldrem, Gheath Alatrash
Journal: Blood
Blood (2022) 140 (Supplement 1): 7392–7393.
https://doi.org/10.1182/blood-2022-166488
Published: 2022